The French pharma major has started a $15.50 per share cash tender offer for Emeryville, California-based Dynavax, which ...

In the latest of a flurry of announcements ahead of the holiday period, CMS has revealed a new, voluntary access programme ...

In labs, water consumption and single-use plastics like pipette tips can contribute to environmental impact. Lab equipment ...

Months of uncertainty have come to a close. The BIOSECURE Act, now part of the National Defense Authorization Act (NDAA), will put in motion US government-wide restrictions on ‘biotechnology companies ...

The FDA has delivered a gift to Novo Nordisk ahead of the holiday season, with the prompt approval of an oral formulation of ...

"Our goal in the LATIFY trial was to reinvigorate the immune response of patients with lung cancer whose tumours stopped ...

People in life sciences companies understand how patents are crucial to their business, by setting competitive boundaries, ...

It's notable that Ipsen has bolted on more than 20 early-stage programmes since 2020 as part of a push to become a major ...

The Centers for Medicare & Medicaid Services (CMS) has proposed two more programmes in the Trump administration's efforts to ...

In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Tarek Samad, Lundbeck’s senior vice president and head ...

AstraZeneca will voluntarily take its anticoagulant reversal agent Andexxa off the market in the US in light of FDA concerns ...